FAERMARK, I. F.;GUSS, L. T.;ERSHOV, L. V.;SHVARTS, G. YA.;GRANIK, V. G., XIM.-FARMATS. ZH., 24,(1990) N, S. 27-29
作者:FAERMARK, I. F.、GUSS, L. T.、ERSHOV, L. V.、SHVARTS, G. YA.、GRANIK, V. G.
DOI:——
日期:——
[EN] COMBINATIONS<br/>[FR] COMBINAISONS
申请人:RECURIUM IP HOLDINGS LLC
公开号:WO2021127039A1
公开(公告)日:2021-06-24
Disclosed herein are combinations of compounds for treating a disease or condition, such as cancer. A combination of compounds for treating a disease or condition can include a WEE1 inhibitor, and a SERD or SERM inhibitor, along with pharmaceutically acceptable salts of any of the foregoing.
[EN] MONO- AND COMBINATION THERAPIES<br/>[FR] MONOTHÉRAPIES ET POLYTHÉRAPIES
申请人:RECURIUM IP HOLDINGS LLC
公开号:WO2021231653A1
公开(公告)日:2021-11-18
Disclosed herein are compounds and combinations of compounds for treating a disease or condition, such as cancer.
SMETSKAYA, N. I.;MUXINA, N. A.;GRANIK, V. G.;SHVARTS, G. YA.;SYUBAEV, R. +, XIM.-FARMATS. ZH., 1984, N 8, 931-935
作者:SMETSKAYA, N. I.、MUXINA, N. A.、GRANIK, V. G.、SHVARTS, G. YA.、SYUBAEV, R. +